Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Total Current Liabilities (2016 - 2025)

Ligand Pharmaceuticals' Total Current Liabilities history spans 16 years, with the latest figure at $64.7 million for Q2 2025.

  • For Q2 2025, Total Current Liabilities rose 248.69% year-over-year to $64.7 million; the TTM value through Jun 2025 reached $64.7 million, up 248.69%, while the annual FY2024 figure was $37.1 million, 121.14% up from the prior year.
  • Total Current Liabilities for Q2 2025 was $64.7 million at Ligand Pharmaceuticals, up from $58.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $98.9 million in Q1 2023 and bottomed at $15.7 million in Q3 2023.
  • The 5-year median for Total Current Liabilities is $37.1 million (2024), against an average of $44.3 million.
  • The largest annual shift saw Total Current Liabilities plummeted 83.02% in 2023 before it surged 248.69% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $41.7 million in 2021, then skyrocketed by 137.15% to $98.8 million in 2022, then tumbled by 83.02% to $16.8 million in 2023, then skyrocketed by 121.14% to $37.1 million in 2024, then skyrocketed by 74.43% to $64.7 million in 2025.
  • Per Business Quant, the three most recent readings for LGND's Total Current Liabilities are $64.7 million (Q2 2025), $58.7 million (Q1 2025), and $37.1 million (Q4 2024).